InsiderTrades

Form 4 for MREO Mereo BioPharma Group plc

Accepted 2024-05-23 00:00:00 ET · period of report 2024-05-22 · accession 0000950170-24-064274 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-05-23 2024-05-22 MREO Hughes-Wilson Alexandra See Remarks F - Tax $1.26 -67.9K 7,650 -90% -$85.3K
DM 2024-05-23 2024-05-22 MREO Hughes-Wilson Alexandra See Remarks M - OptEx $1.23 +168.3K 82.7K New +$206.4K
DM 2024-05-23 2024-05-22 MREO Hughes-Wilson Alexandra See Remarks S - Sale+OE $2.97 -100.4K 32.6K -76% -$297.8K
DM 2024-05-23 2024-05-22 MREO Hughes-Wilson Alexandra See Remarks M - OptEx $1.23 -168.3K 0 -100% -$206.4K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common American Depositary Shares representing Ordinary Shares 2024-05-22 F D 24,918 $1.01 7,650 D — — (F1) Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
2 Common American Depositary Shares representing Ordinary Shares 2024-05-22 M A 93,333 $1.40 100,983 D — — (F1) Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
3 Common American Depositary Shares representing Ordinary Shares 2024-05-22 S D 50,350 $2.99 58,633 D — — (F1) Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $2.88 to $3.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges
4 Common American Depositary Shares representing Ordinary Shares 2024-05-22 F D 42,983 $1.40 7,650 D — — (F1) Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
5 Common American Depositary Shares representing Ordinary Shares 2024-05-22 M A 75,000 $1.01 82,650 D — — (F1) Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer.
6 Common American Depositary Shares representing Ordinary Shares 2024-05-22 S D 50,082 $2.94 32,568 D — — (F1) Each American Depositary Share ("ADS") represents five ordinary shares, nominal value GBP 0.003 per ordinary share, of the Issuer. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $2.88 to $3.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges
7 Derivative Share Options (Right to buy) 2024-05-22 M D 93,333 $1.40 0 D $1.40 · — to 2032-01-14 93,333 American Depositary Shares (F4) 160,000 options were issued on 01/14/2022 and 25% of the shares underlying this award became exercisable on January 14, 2023, with the remainder vesting in equal monthly installments thereafter.
8 Derivative Share Options (Right to buy) 2024-05-22 M D 75,000 $1.01 0 D $1.01 · — to 2033-01-25 75,000 American Depositary Shares (F5) 240,000 options were issued on 01/25/2023 and 25% of the shares underlying this award became exercisable on January 25, 2024, with the remainder vesting in equal monthly installments thereafter.